Welcome to our dedicated page for Fortrea Holdings SEC filings (Ticker: FTRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Fortrea Holdings Inc. filings document the public-company disclosures of a Nasdaq-listed contract research organization. The company’s 8-K reports furnish operating results and financial condition updates, including revenue, profitability measures, book-to-bill metrics, guidance and related press release exhibits.
Fortrea’s regulatory filings also cover proxy governance, annual meeting matters, board composition, executive compensation and inducement award plans. Capital-structure disclosures include common stock, rights to purchase Series A preferred stock, senior secured notes activity and other debt or equity matters tied to the company’s clinical development services business.
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC report beneficial ownership of 8,031,366.47 shares of Fortrea Holdings Inc. common stock, representing 8.9% of the class. The filing shows no sole voting or dispositive power and records shared voting power of 8,028,366.47 and shared dispositive power of 8,031,366.47, indicating the position is held collectively rather than by a single controlling party.
The filing identifies GS Group as a parent holding company and Goldman Sachs & Co. LLC as a broker/dealer and registered investment adviser and includes a joint filing agreement (Exhibit 99.1) and subsidiary identification (Exhibit 99.2). The statement certifies the securities were acquired and are held in the ordinary course of business and not to change or influence control of the issuer.
Fortrea Holdings director Peter M. Neupert reported two open-market purchases of the issuer's common stock: 30,000 shares on 08/08/2025 at a weighted average price of $6.79, and 32,500 shares on 08/11/2025 at a weighted average price of $6.26. The filing notes the trades were executed in multiple fills at price ranges of $6.69–$6.90 and $6.15–$6.39, respectively.
After these transactions the reporting person beneficially owned 98,132 shares. The Form 4 was signed by an attorney-in-fact on 08/11/2025. No derivative transactions or dispositions were reported on this form.